As companies of all sizes– largecap to smallcap –get leaner to weather the ongoing financial storm, it has become a full time job to keep track of who is cutting whom and by how much. Medical Device and Diagnostic News has created a site to do just that, as part of its DeviceSpace.com blog http://devicespace.com/news_subject_all_results.aspx?CatagoryId=40074. Companies from Siemens and Medtronic to small caps like GeneNews (DEN.TO), Angiotech Pharmaceuticals (ANPI), Northstar Neuroscience (NSTR), Advanced Medical Optics (EYE) and SurModics (SRDX) have made the list in recent weeks. Topping the chart is BIOLASE Technology (BLTI), which Tuesday announced cost savings initiatives that include a 20 percent reduction in its domestic workforce while leaving research and development funding untouched. Go to Med Tech Sentinel http://www.onemedplace.com/blog/archives/1056 for its take on the BIOLASE announcement.